Gene · 10153
Papers2,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy. | Sci Rep | 2023 | 38071228 | PubTator, text mining | PubMed |
| Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world. | Cancer Med | 2023 | 38062912 | PubTator, text mining | PubMed |
| [Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2023)]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049312 | PubTator, text mining | PubMed |
| Resource Utilization Groups in transitional home care: validating the RUG-III/HC case-mix system in hospital-to-home care programs. | BMC Health Serv Res | 2023 | 38037101 | PubTator, text mining | PubMed |
| Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia. | Cancer Biol Ther | 2023 | 38031921 | PubTator, text mining | PubMed |
| Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis. | Front Mol Biosci | 2023 | 38028538 | PubTator, text mining | PubMed |
| Prevalence and Prognosis of Secondary Genetic Aberrations Among Patients With Core Binding Factor Acute Myeloid Leukemia: A Mitelman Database Analysis. | World J Oncol | 2023 | 38022406 | PubTator, text mining | PubMed |
| A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment. | Pharmaceuticals (Basel) | 2023 | 38004478 | PubTator, text mining | PubMed |
| Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest. | Cancers (Basel) | 2023 | 38001621 | PubTator, text mining | PubMed |
| Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML. | Cell Rep Med | 2023 | 37992684 | PubTator, text mining | PubMed |
| Ferritin microheterogeneity, subunit composition, functional, and physiological implications. | Sci Rep | 2023 | 37963965 | PubTator, text mining | PubMed |
| Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy. | Cancers (Basel) | 2023 | 37958332 | PubTator, text mining | PubMed |
| A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia. | Front Med (Lausanne) | 2023 | 37942413 | PubTator, text mining | PubMed |
| Low-dose decitabine-intensified modified conditioning regimen alleviates aGVHD in AML/MDS patients treated with allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2023 | 37928518 | PubTator, text mining | PubMed |
| Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension. | Int J Biol Sci | 2023 | 37928257 | PubTator, text mining | PubMed |
| Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia. | Blood Res | 2023 | 37926557 | PubTator, text mining | PubMed |
| Epigenetic regulation in lung cancer. | MedComm (2020) | 2023 | 37901797 | PubTator, text mining | PubMed |
| Comparison Study of Small Extracellular Vesicle Isolation Methods for Profiling Protein Biomarkers in Breast Cancer Liquid Biopsies. | Int J Mol Sci | 2023 | 37895140 | PubTator, text mining | PubMed |
Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year. | Cancers (Basel) | 2023 | 37894431 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Provides Insight into Skeletal Muscle Evolution during the Selection of Muscle Characteristics. | Adv Sci (Weinh) | 2023 | 37870215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10153/papers?page=10